COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence.
COVID-19
epidemiology
occupation-related infections
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
21 02 2022
21 02 2022
Historique:
pubmed:
22
2
2022
medline:
12
3
2022
entrez:
21
2
2022
Statut:
epublish
Résumé
SARS-CoV-2 serological tests are used to assess the infection seroprevalence within a population. This study aims at assessing potential biases in estimating infection prevalence amongst healthcare workers (HCWs) when different diagnostic criteria are considered. A multi-site cross-sectional study was carried out in April-September 2020 amongst 1.367 Italian HCWs. SARS-CoV-2 prevalence was assessed using three diagnostic criteria: RT-PCR on nasopharyngeal swab, point-of-care fingerprick serological test (POCT) result and COVID-19 clinical pathognomonic presentation. A logistic regression model was used to estimate the probability of POCT-positive result in relation to the time since infection (RT-PCR positivity). Among 1.367 HCWs, 69.2% were working in COVID-19 units. Statistically significant differences in age, role and gender were observed between COVID-19/non-COVID-19 units. Prevalence of SARS-CoV-2 infection varied according to the criterion considered: 6.7% for POCT, 8.1% for RT-PCR, 10.0% for either POCT or RT-PCR, 9.6% for infection pathognomonic clinical presentation and 17.6% when at least one of the previous criteria was present. The probability of POCT-positive result decreased by 1.1% every 10 days from the infection. This study highlights potential biases in estimating SARS-CoV-2 point-prevalence data according to the criteria used. Although informative on infection susceptibility and herd immunity level, POCT serological tests are not the best predictors of previous COVID-19 infections for public health monitoring programmes.
Identifiants
pubmed: 35184764
doi: 10.1017/S0950268822000280
pii: S0950268822000280
pmc: PMC8914136
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e48Subventions
Organisme : This study was funded by Cariverona Foundation (ENACT Fund 2020), Italy
Références
Am J Clin Pathol. 2020 Jun 8;154(1):1-3
pubmed: 32412044
J Clin Virol. 2016 Mar;76:8-13
pubmed: 26774543
PLoS One. 2020 Dec 28;15(12):e0244477
pubmed: 33370384
Lancet. 2020 Jul 25;396(10246):e6-e7
pubmed: 32653078
Infect Control Hosp Epidemiol. 2021 Feb;42(2):212-214
pubmed: 32746953
J Med Virol. 2020 Jun;92(6):577-583
pubmed: 32162702
J Hosp Infect. 2021 Feb;108:120-134
pubmed: 33212126
Clin Microbiol Infect. 2021 Feb;27(2):182-191
pubmed: 32120036
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541
Clin Chem Lab Med. 2020 Aug 26;58(12):2107-2111
pubmed: 32845861
Lancet Respir Med. 2020 Sep;8(9):885-894
pubmed: 32717210
Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652
pubmed: 32584464
Sex Transm Infect. 2017 Dec;93(S4):S51-S58
pubmed: 29223963
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):269-283
pubmed: 33589829
Science. 2021 Jan 8;371(6525):126-127
pubmed: 33414210
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33080168
Am J Emerg Med. 2020 Sep;38(9):1727-1731
pubmed: 32738467
Am J Clin Pathol. 2020 Aug 5;154(3):425-426
pubmed: 32577723
Malays J Pathol. 2020 Apr;42(1):13-21
pubmed: 32342927
J Infect. 2020 Jun;80(6):656-665
pubmed: 32283155
Am J Otolaryngol. 2020 Sep - Oct;41(5):102581
pubmed: 32563019
Int J Epidemiol. 2021 May 17;50(2):400-409
pubmed: 33434269
Cochrane Database Syst Rev. 2020 Aug 26;8:CD013705
pubmed: 32845525
Am J Infect Control. 2021 Jan;49(1):21-29
pubmed: 32659413
BMJ. 2020 Jul 1;370:m2516
pubmed: 32611558
BMJ. 2020 Oct 28;371:m3944
pubmed: 33115772